European Commission grants ODD to NS-229 for treatment of Eosinophilic Granulomatosis
The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
This product has sales of about US$ 20 million in Europe
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
His most recent stint was with Danone India as its Managing Director
Subscribe To Our Newsletter & Stay Updated